Live
- ICC chief Jay Shah meets Brisbane 2032 Olympics organising committee CEO
- Oxford Grammar High School Celebrates 44th Annual Sports Day with Grandeur
- Indian banking sector’s health remains robust, govt policy working very well: Top bankers
- iOS 18.2 Unveiled: New Features with ChatGPT Integration Revolutionize Your iPhone
- 'Run for Viksit Rajasthan' to be annual event, says CM Sharma
- Nitish Kumar launches '109 free medicine vehicles' in Patna
- India have to play their best cricket at the Gabba to win series: Harbhajan
- Income tax refunds jump 46.3 pc to Rs 3.04 lakh crore in April-Nov
- Financial Intelligence Unit detects undisclosed income worth Rs 11,000 crore in 2024: Centre
- Odisha BJP chief to be elected in January
Patient left dead in France after clinical trial
A brain-dead patient died after having participated in clinical trial in the Teaching Hoispital of Rennes (Britanny, France).
"The brain-dead patient died in the middle of the day in Teaching Hospital of Rennes ", according to TH statement.
A brain-dead patient died after having participated in clinical trial in the Teaching Hoispital of Rennes (Britanny, France).
This study was conducted on eighty four patients, five of them received a larger dose and four experienced neurological disorder which seriousness has not been indicated yet.
This drug test was conducted by Biotrial Clinical Research Organization, whose reliability has been saluted by French Health Minister Marisol Touraine:"This research institute is known for conducting studies seriously". Biotrial conducted the tests on behalf of Bial, a Portuegese drug manufacturer.
Every year, thousands of people, mostly students, participate in clinical trials to pay for their education.
